🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Vitiligo is a complex disease causing a selective, often progressive, loss ...
Status
Unknown
Location
PGIMER
Start Date
2016-01
Trial ID
NCT03013049
Treatments Being Tested
Overweight and obesity have reached worldwide epidemic level. Both overweig...
Status
Completed
Location
Cliniques universitaires Saint-Luc
Start Date
2015-12
Trial ID
NCT02637115
Treatments Being Tested
Rotavirus, sometimes called the "stomach flu," is the most common cause of ...
Status
Completed
Location
Kaiser Permanente Vaccine Study Center
Start Date
2011-03
Trial ID
NCT01266850
Phase 2b trial evaluating the safety and efficacy of EGP-437, versus placeb...
Status
Completed
Location
Site 901
Start Date
2017-07-26
Trial ID
NCT03180255
Treatments Being Tested
Our recent trials combining local radiotherapy with intratumoral administra...
Status
Completed
Location
Icahn School of Medicine at Mount Sinai
Start Date
2014-01-03
Trial ID
NCT01976585
Treatments Being Tested
The objective of this 2 hour study is to evaluate the clinical performance ...
Status
Completed
Location
Bausch and Lomb Site 01
Start Date
2021-09-15
Trial ID
NCT05129488
Emergence delirium (ED) from general anesthesia posts risk and harm to pedi...
Status
Completed
Location
St Luke's-Roosevelt Hospital Center
Start Date
2009-08
Trial ID
NCT00857727
Treatments Being Tested
Keloids affect upto 16% of Africans causing significant cosmetic, functiona...
Status
Unknown
Location
Department of Surgery, Makerere University College of Health Sciences
Start Date
2021-05-01
Trial ID
NCT04391621
Preliminary safety and efficacy of XT-150 in the synovial capsule of osteoa...
Status
Withdrawn
Location
Alfred Health
Start Date
2021-10
Trial ID
NCT04841512
Treatments Being Tested
The study is a first-in-human Phase 1/2a randomized, double-blind, placebo-...
Status
Suspended
Location
UPMC Presbyterian
Start Date
2023-10-25
Trial ID
NCT05715619